152 related articles for article (PubMed ID: 2776655)
1. Estimation of cholesterol loading of the low-density lipoprotein fraction in diabetic subjects without ultracentrifugation.
Yoshino G; Iwai M; Matsuba K; Iwatani I; Matsushita M; Kazumi T; Baba S
Diabetes Res Clin Pract; 1989 Aug; 7(2):155-7. PubMed ID: 2776655
[TBL] [Abstract][Full Text] [Related]
2. Hyperapobetalipoproteinemia with compositional abnormality of LDL and IDL, a characteristic lipoprotein alteration in essential hypertension.
Ryomoto KI; Suzuki M; Kanazawa A; Hasegawa M; Kimura Y; Yamamura T; Harano Y
Am J Hypertens; 2000 Jun; 13(6 Pt 1):617-24. PubMed ID: 10912744
[TBL] [Abstract][Full Text] [Related]
3. Hyperbetalipoproteinemia with small low-density lipoprotein, a characteristic disorder of lipoprotein in essential hypertension.
Ikeda K; Suzuki M; Ikebuchi M; Hara Y; Tsushima M; Yamamoto A; Harano Y
J Diabetes Complications; 1995; 9(4):227-9. PubMed ID: 8573733
[TBL] [Abstract][Full Text] [Related]
4. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
5. Phenotypes of hypertriglyceridemia caused by excess very-low-density lipoprotein.
Sniderman AD; Tremblay A; De Graaf J; Couture P
J Clin Lipidol; 2012; 6(5):427-33. PubMed ID: 23009778
[TBL] [Abstract][Full Text] [Related]
6. Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulin-dependent diabetes.
Howard BV; Abbott WG; Beltz WF; Harper IT; Fields RM; Grundy SM; Taskinen MR
Metabolism; 1987 Sep; 36(9):870-7. PubMed ID: 3626866
[TBL] [Abstract][Full Text] [Related]
7. Comparison of methods for measurement of apolipoprotein B and cholesterol in low-density lipoproteins.
Vrga L; Contacos C; Li SC; Sullivan DR
Clin Chem; 1997 Feb; 43(2):390-3. PubMed ID: 9023145
[TBL] [Abstract][Full Text] [Related]
8. [Cholesterol, phospholipid and apoB composition of LDL: comparison of precipitation and ultracentrifugation methods].
Mainard F; Madec Y
Ann Biol Clin (Paris); 1986; 44(6):618-23. PubMed ID: 3826778
[TBL] [Abstract][Full Text] [Related]
9. Spectrophotometry and Ultracentrifugation for Measurement of Plasma Lipids in Dogs with Diabetes Mellitus.
Seage EC; Drobatz KJ; Hess RS
J Vet Intern Med; 2018 Jan; 32(1):93-98. PubMed ID: 29193277
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
[TBL] [Abstract][Full Text] [Related]
11. Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels.
Leroux G; Lemieux I; Lamarche B; Cantin B; Dagenais GR; Lupien PJ; Després JP
Metabolism; 2000 Jan; 49(1):53-61. PubMed ID: 10647064
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
Ginsberg HN; Le NA; Gibson JC
J Clin Invest; 1985 Feb; 75(2):614-23. PubMed ID: 3973021
[TBL] [Abstract][Full Text] [Related]
13. Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease.
Karpe F; Hellénius ML; Hamsten A
Metabolism; 1999 Mar; 48(3):301-7. PubMed ID: 10094104
[TBL] [Abstract][Full Text] [Related]
14. Abnormal lipoprotein composition in normolipidemic diabetic patients.
Iwai M; Yoshino G; Matsushita M; Morita M; Matsuba K; Kazumi T; Baba S
Diabetes Care; 1990 Jul; 13(7):792-6. PubMed ID: 2201502
[TBL] [Abstract][Full Text] [Related]
15. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
[TBL] [Abstract][Full Text] [Related]
18. Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.
Walsh BW; Sacks FM
J Clin Invest; 1993 May; 91(5):2126-32. PubMed ID: 8486779
[TBL] [Abstract][Full Text] [Related]
19. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus.
Kissebah AH; Alfarsi S; Evans DJ; Adams PW
Diabetes; 1982 Mar; 31(3):217-25. PubMed ID: 7152129
[TBL] [Abstract][Full Text] [Related]
20. The spectrum of type III hyperlipoproteinemia.
Sniderman AD; de Graaf J; Thanassoulis G; Tremblay AJ; Martin SS; Couture P
J Clin Lipidol; 2018; 12(6):1383-1389. PubMed ID: 30318453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
